Status:

COMPLETED

Prevention of Progression of Duodenal Adenomas in Patients With Familial Adenomatous Polyposis

Lead Sponsor:

Radboud University Medical Center

Collaborating Sponsors:

Dutch Cancer Society

Conditions:

Familial Adenomatous Polyposis

Duodenal Neoplasms

Eligibility:

All Genders

18-70 years

Phase:

PHASE2

PHASE3

Brief Summary

Duodenal carcinomas are the leading cause of mortality in patients with Familial Adenomatous Polyposis (FAP) who underwent prophylactic colorectal surgery. The purpose of this study is to determine we...

Eligibility Criteria

Inclusion

  • Patients with Familial adenomatous Polyposis: APC-mutation identified or more than 100 colorectal polyps on diagnosis
  • Spigelman score of duodenal adenoma equal to II or III

Exclusion

  • Incapability of signing informed consent
  • Active gastric or duodenal ulcer, gastrointestinal bleeding
  • Cardiovascular disease or risk:
  • Congestive cardiac failure: NYHA class II to IV
  • Proven ischemic heart disease and/or cerebrovascular disease
  • Risk factors: hypertension, hyperlipidaemia, diabetes mellitus, family history of cardiovascular events (≥2 first degree family members \<55 years)
  • Renal dysfunction: creatinine clearance below 50mL/min
  • Liver dysfunction: albumin below 25 g/L or Child-Pugh-score equal to or below 10
  • Known allergic reaction to sulfonamides, NSAIDs or ursodeoxycholic acid
  • Use of NSAIDs or ursodeoxycholic acid for more than 1 week during the 6 months prior to the start of the study
  • Use of lithium
  • Symptomatic gallstones
  • Inflammatory bowel disease
  • (Possible) pregnancy or breast feeding

Key Trial Info

Start Date :

May 1 2009

Trial Type :

INTERVENTIONAL

Allocation :

ACTUAL

End Date :

January 1 2013

Estimated Enrollment :

37 Patients enrolled

Trial Details

Trial ID

NCT00808743

Start Date

May 1 2009

End Date

January 1 2013

Last Update

May 16 2013

Active Locations (5)

Enter a location and click search to find clinical trials sorted by distance.

Page 1 of 2 (5 locations)

1

Academic Medical Center

Amsterdam, Netherlands

2

University Medical Center

Groningen, Netherlands

3

Leiden University Medical Center

Leiden, Netherlands

4

University Medical Center St. Radboud

Nijmegen, Netherlands